FDA
-
-
-
-
-
-
-
Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events
-
-
-
-
-
-
-
Correvio Announces Presentation of New Brinavess™ Spectrum Data at the American Heart Association 2019 Annual Meeting
-
-
-
-
-
-
-
Correvio Reports Second Quarter 2019 Financial Results
-
-
-
-
-
-
-
Correvio Reports Fourth Quarter and Full Year 2018 Financial Results
-
-
-
-
-
-
-
Correvio Announces Brinavess Eligibility for Patent Extension
-
-
-
-
-
-
-
Correvio Announces Brinavess® Selected as Potentially Eligible for Priority Review in China
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

